EP

Eloxx Pharmaceuticals

Israel - Nes Tziona
Pharmaceutical

Focus: Rare Genetic Diseases

Eloxx Pharmaceuticals is a life sciences company focused on Rare Genetic Diseases.

Rare DiseasesNeurology
Funding Stage
PUBLIC
Open Jobs
0

Pipeline & Clinical Trials

Phase 1
Clinical Trials (1)
NCT03309605Phase 1 Study of ELX-02 in Healthy Adult Subjects
Phase 1
Phase 1
Clinical Trials (1)
NCT03292302Phase 1 Study of ELX-02 in Healthy Adults
Phase 1
Clinical Trials (1)
NCT03776539A Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics of ELX-02
Phase 1
Phase 1
Clinical Trials (1)
NCT02807961Safety, Tolerability, Pharmacokinetics of ELX-02 in Healthy Adult Volunteers
Phase 1
Phase 2
Clinical Trials (1)
NCT04126473A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD in Cystic Fibrosis Patients With at Least 1 G542X Allele
Phase 2
Phase 2
Clinical Trials (1)
NCT05448755A Study of ELX-02 in Patients With Alport Syndrome
Phase 2
Phase 2
Clinical Trials (1)
NCT04069260A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis
Phase 2
Phase 2
Clinical Trials (1)
NCT04135495A Phase 2 Study to Evaluate the Safety, Tolerability, PK and PD of ELX-02 in Cystic Fibrosis Patients With G542X Allele
Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 8 clinical trials

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles